These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37408777)
21. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironment. Zhu Z; Ye W; Wu X; Lin S; Xu J; Li L; Li J; Wang H; Huang Z Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350431 [TBL] [Abstract][Full Text] [Related]
23. Gene expression patterns associated with tumor-infiltrating CD4+ and CD8+ T cells in invasive breast carcinomas. Wang Z; Yang X; Shen J; Xu J; Pan M; Liu J; Han S Hum Immunol; 2021 Apr; 82(4):279-287. PubMed ID: 33612391 [TBL] [Abstract][Full Text] [Related]
24. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation. Chen X; Zheng J; Zhuo ML; Zhang A; You Z Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733 [TBL] [Abstract][Full Text] [Related]
25. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
26. Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment. Zhang G Front Immunol; 2022; 13():975762. PubMed ID: 36189226 [TBL] [Abstract][Full Text] [Related]
27. 9-Gene Signature Correlated With CD8 Yan K; Lu Y; Yan Z; Wang Y Front Immunol; 2021; 12():622563. PubMed ID: 34220795 [TBL] [Abstract][Full Text] [Related]
28. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920 [TBL] [Abstract][Full Text] [Related]
29. Performance of a PLK1-based immune risk model for prognosis and treatment response prediction in breast cancer. Chen Y; You Y; Wu Q; Wu J; Lin S; Sun Y; Cui Z Cancer Med; 2023 May; 12(9):11020-11039. PubMed ID: 36951624 [TBL] [Abstract][Full Text] [Related]
30. Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model. Trofimova O; Korotkaja K; Skrastina D; Jansons J; Spunde K; Isaguliants M; Zajakina A Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835178 [TBL] [Abstract][Full Text] [Related]
31. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
32. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction. Sun Y; Yang M; Zhang Q Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642 [TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma. Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of Ferroptosis-related Gene Zhang Z; Qiu X; Yan Y; Liang Q; Cai Y; Peng B; Xu Z; Xia F Int J Gen Med; 2021; 14():6189-6200. PubMed ID: 34611432 [TBL] [Abstract][Full Text] [Related]
35. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer. Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298 [TBL] [Abstract][Full Text] [Related]
36. Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer. Tan M; Huang G; Chen J; Yi J; Liu X; Liao N; Hu Y; Zhou W; Guo Q Am J Transl Res; 2022; 14(5):2779-2800. PubMed ID: 35702100 [TBL] [Abstract][Full Text] [Related]
37. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
38. STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment. Pu Z; Liu J; Liu Z; Peng F; Zhu Y; Wang X; He J; Yi P; Hu X; Fan X; Chen J Cancer Cell Int; 2022 Oct; 22(1):314. PubMed ID: 36224658 [TBL] [Abstract][Full Text] [Related]
39. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. Padua D; Mahurkar-Joshi S; Law IK; Polytarchou C; Vu JP; Pisegna JR; Shih D; Iliopoulos D; Pothoulakis C Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G446-57. PubMed ID: 27492330 [TBL] [Abstract][Full Text] [Related]
40. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration. Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]